Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Tolperisone (Primary) ; Cyclobenzaprine
- Indications Muscle hypertonia; Muscle spasticity; Spasm
- Focus Therapeutic Use
- Sponsors Neurana Pharmaceuticals
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 26 Oct 2017 Primary endpoint (Standard Deviation of Lateral Position (SDLP)) has been met according to a Neurana Pharmaceuticals media release.
- 26 Oct 2017 Top-line results presented in a Neurana Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History